Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$85.75 USD

85.75
879,016

+0.30 (0.35%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $85.74 -0.01 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (145 out of 244)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Alcon (ALC) Vision Care Sales Robust, Margin Pressure Persists

by Zacks Equity Research

For Alcon (ALC), in terms of end market, Surgical global cataract procedure growth varies significantly by region.

Zacks Equity Research

Alcon (ALC) Q1 Earnings Surpass Estimates, 23' EPS View Up

by Zacks Equity Research

Alcon (ALC) Q1 revenues were driven by strong consumables and equipment sales.

Zacks Equity Research

Alcon (ALC) to Report Q1 Earnings: What's in the Cards?

by Zacks Equity Research

Amid persistent supply-chain headwinds, Alcon's (ALC) first-quarter top-line results are likely to reflect the commercial execution of new product launches across its segments and contributions from strategic alliances.

Zacks Equity Research

ALC or EW: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ALC vs. EW: Which Stock Is the Better Value Option?

Zacks Equity Research

Philips (PHG) Drives Healthcare Prospects With Enhanced Dataset

by Zacks Equity Research

Philips (PHG) announces its expansion with MIT IMES, which will help researchers and educators access a new critical care dataset.

Zacks Equity Research

ALC vs. IDXX: Which Stock Is the Better Value Option?

by Zacks Equity Research

ALC vs. IDXX: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why You Should Retain Centene (CNC) in Your Portfolio

by Zacks Equity Research

Strong membership growth, contract wins, accretive acquisitions and streamlining of businesses poise Centene (CNC) well for growth.

Zacks Equity Research

What Makes Alcon (ALC) a New Buy Stock

by Zacks Equity Research

Alcon (ALC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

by Zacks Equity Research

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Zacks Equity Research

Here's Why You Should Retain McKesson (MCK) Stock for Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Zacks Equity Research

Are Medical Stocks Lagging Adagene (ADAG) This Year?

by Zacks Equity Research

Here is how Adagene Inc. Sponsored ADR (ADAG) and Alcon (ALC) have performed compared to their sector so far this year.

Zacks Equity Research

Philips (PHG) Drives Health Care Prospects With New Solutions

by Zacks Equity Research

Philips (PHG) announces Philips Virtual Care Management solutions, which provide a comprehensive approach to telehealth for patients, providers and payers.

Zacks Equity Research

Encompass Health (EHC) Opens JV Hospital for Oklahoma Patients

by Zacks Equity Research

Encompass Health (EHC) inaugurated the Owasso-based Ascension St. John Rehabilitation Hospital, that it will operate jointly with Ascension St. John to offer rehabilitative care in Oklahoma.

Zacks Equity Research

Here's Why You Should Retain Elevance (ELV) in Your Portfolio

by Zacks Equity Research

Strong local presence, improving top line, membership hike and significant new contracts in its government business poise Elevance Health (ELV) well for growth.

Zacks Equity Research

ALC vs. ISRG: Which Stock Is the Better Value Option?

by Zacks Equity Research

ALC vs. ISRG: Which Stock Is the Better Value Option?

Zacks Equity Research

Here's Why You Should Retain McKesson (MCK) Stock Right Now

by Zacks Equity Research

McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.

Zacks Equity Research

Reasons to Retain ShockWave Medical (SWAV) in Your Portfolio

by Zacks Equity Research

ShockWave Medical (SWAV) continues to benefit from solid R&D endeavors and its commitment to clinical studies.

Zacks Equity Research

Acadia Healthcare (ACHC) to Build Behavioral Health Unit in Mesa

by Zacks Equity Research

Acadia Healthcare (ACHC) begins the construction of its Mesa-based behavioral health hospital to address the inadequacy of behavioral healthcare resources in Arizona.

Zacks Equity Research

Is Addus HomeCare (ADUS) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research

Here is how Addus HomeCare (ADUS) and Alcon (ALC) have performed compared to their sector so far this year.

Zacks Equity Research

Alcon (ALC) Unveils Expansive Vision Care Products at SECO 2023

by Zacks Equity Research

Alcon (ALC) showcases its reusable toric lens and dry eye/ocular health offerings at the SECO International Meeting 2023 in Atlanta.

Zacks Equity Research

ALC vs. ISRG: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ALC vs. ISRG: Which Stock Is the Better Value Option?

Zacks Equity Research

Alcon (ALC) Q4 Earnings Match Estimates, Margins Contract

by Zacks Equity Research

Alcon (ALC) reports impressive CER growth in net sales across all segments in the fourth quarter amid a challenging macroeconomic environment.

Mark Vickery headshot

Top Stock Reports for Costco Wholesale, Intuit & Schlumberger

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Costco Wholesale Corporation (COST), Intuit Inc. (INTU) and Schlumberger Limited (SLB).

Zacks Equity Research

Alcon (ALC) Gains From Innovation, Faces FX Challenges

by Zacks Equity Research

Alcon's (ALC) Surgical franchise continues to lead the market with its portfolio of advanced technology, intraocular lenses, a substantial installed base of equipment and a growing consumable base.

Zacks Equity Research

Alcon's (ALC) Latest Buyout to Enhance Its Product Portfolio

by Zacks Equity Research

Alcon's (ALC) ophthalmic pharmaceutical product suite is expected to be significantly boosted by adding new products following the recent acquisition.